185 related articles for article (PubMed ID: 32681389)
1. Pleiotrophin selectively binds to vascular endothelial growth factor receptor 2 and inhibits or stimulates cell migration depending on α
Lamprou M; Kastana P; Kofina F; Tzoupis Η; Barmpoutsi S; Sajib MS; Koutsioumpa M; Poimenidi E; Zompra AA; Tassopoulos D; Choleva E; Tselios T; Mikelis CM; Papadimitriou E
Angiogenesis; 2020 Nov; 23(4):621-636. PubMed ID: 32681389
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor A (VEGF-A) decreases expression and secretion of pleiotrophin in a VEGF receptor-independent manner.
Poimenidi E; Theodoropoulou C; Koutsioumpa M; Skondra L; Droggiti E; van den Broek M; Koolwijk P; Papadimitriou E
Vascul Pharmacol; 2016 May; 80():11-9. PubMed ID: 26924457
[TBL] [Abstract][Full Text] [Related]
3. Cyclin-dependent kinase 5 mediates pleiotrophin-induced endothelial cell migration.
Lampropoulou E; Logoviti I; Koutsioumpa M; Hatziapostolou M; Polytarchou C; Skandalis SS; Hellman U; Fousteris M; Nikolaropoulos S; Choleva E; Lamprou M; Skoura A; Megalooikonomou V; Papadimitriou E
Sci Rep; 2018 Apr; 8(1):5893. PubMed ID: 29651006
[TBL] [Abstract][Full Text] [Related]
4. Pleiotrophin-induced endothelial cell migration is regulated by xanthine oxidase-mediated generation of reactive oxygen species.
Tsirmoula S; Lamprou M; Hatziapostolou M; Kieffer N; Papadimitriou E
Microvasc Res; 2015 Mar; 98():74-81. PubMed ID: 25582077
[TBL] [Abstract][Full Text] [Related]
5. A peptide corresponding to the C-terminal region of pleiotrophin inhibits angiogenesis in vivo and in vitro.
Mikelis C; Lamprou M; Koutsioumpa M; Koutsioubas AG; Spyranti Z; Zompra AA; Spiliopoulos N; Vradis AA; Katsoris P; Spyroulias GA; Cordopatis P; Courty J; Papadimitriou E
J Cell Biochem; 2011 Jun; 112(6):1532-43. PubMed ID: 21344482
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial-cadherin stimulates syndecan-1-coupled insulin-like growth factor-1 receptor and cross-talk between αVβ3 integrin and vascular endothelial growth factor receptor 2 at the onset of endothelial cell dissemination during angiogenesis.
Rapraeger AC; Ell BJ; Roy M; Li X; Morrison OR; Thomas GM; Beauvais DM
FEBS J; 2013 May; 280(10):2194-206. PubMed ID: 23331867
[TBL] [Abstract][Full Text] [Related]
7. Endorepellin laminin-like globular 1/2 domains bind Ig3-5 of vascular endothelial growth factor (VEGF) receptor 2 and block pro-angiogenic signaling by VEGFA in endothelial cells.
Willis CD; Poluzzi C; Mongiat M; Iozzo RV
FEBS J; 2013 May; 280(10):2271-84. PubMed ID: 23374253
[TBL] [Abstract][Full Text] [Related]
8. Recombinant RGD-disintegrin DisBa-01 blocks integrin α
Danilucci TM; Santos PK; Pachane BC; Pisani GFD; Lino RLB; Casali BC; Altei WF; Selistre-de-Araujo HS
Cell Commun Signal; 2019 Mar; 17(1):27. PubMed ID: 30894182
[TBL] [Abstract][Full Text] [Related]
9. Integrin alpha(v)beta(3) is a pleiotrophin receptor required for pleiotrophin-induced endothelial cell migration through receptor protein tyrosine phosphatase beta/zeta.
Mikelis C; Sfaelou E; Koutsioumpa M; Kieffer N; Papadimitriou E
FASEB J; 2009 May; 23(5):1459-69. PubMed ID: 19141530
[TBL] [Abstract][Full Text] [Related]
10. Activating CD137 Signaling Promotes Sprouting Angiogenesis via Increased VEGFA Secretion and the VEGFR2/Akt/eNOS Pathway.
Li B; Zhang Y; Yin R; Zhong W; Chen R; Yan J
Mediators Inflamm; 2020; 2020():1649453. PubMed ID: 33162828
[TBL] [Abstract][Full Text] [Related]
11. The impact of the receptor binding profiles of the vascular endothelial growth factors on their angiogenic features.
Nieminen T; Toivanen PI; Rintanen N; Heikura T; Jauhiainen S; Airenne KJ; Alitalo K; Marjomäki V; Ylä-Herttuala S
Biochim Biophys Acta; 2014 Jan; 1840(1):454-63. PubMed ID: 24112971
[TBL] [Abstract][Full Text] [Related]
12. Receptor protein tyrosine phosphatase beta/zeta is a functional binding partner for vascular endothelial growth factor.
Koutsioumpa M; Poimenidi E; Pantazaka E; Theodoropoulou C; Skoura A; Megalooikonomou V; Kieffer N; Courty J; Mizumoto S; Sugahara K; Papadimitriou E
Mol Cancer; 2015 Feb; 14(1):19. PubMed ID: 25644401
[TBL] [Abstract][Full Text] [Related]
13. Thioredoxin-interacting protein mediates sustained VEGFR2 signaling in endothelial cells required for angiogenesis.
Park SY; Shi X; Pang J; Yan C; Berk BC
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):737-43. PubMed ID: 23393387
[TBL] [Abstract][Full Text] [Related]
14. Integrin alpha x stimulates cancer angiogenesis through PI3K/Akt signaling-mediated VEGFR2/VEGF-A overexpression in blood vessel endothelial cells.
Wang J; Yang L; Liang F; Chen Y; Yang G
J Cell Biochem; 2019 Feb; 120(2):1807-1818. PubMed ID: 30873824
[TBL] [Abstract][Full Text] [Related]
15. FAS1 domain protein inhibits VEGF165-induced angiogenesis by targeting the interaction between VEGFR-2 and αvβ3 integrin.
Nam JO; Son HN; Jun E; Cha K; Lee BH; Park RW; Kim IS
Mol Cancer Res; 2012 Aug; 10(8):1010-20. PubMed ID: 22710795
[TBL] [Abstract][Full Text] [Related]
16. Pleiotrophin, a multifunctional cytokine and growth factor, induces leukocyte responses through the integrin Mac-1.
Shen D; Podolnikova NP; Yakubenko VP; Ardell CL; Balabiyev A; Ugarova TP; Wang X
J Biol Chem; 2017 Nov; 292(46):18848-18861. PubMed ID: 28939773
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of integrin-vascular endothelial growth factor receptor cross-activation in angiogenesis.
Mahabeleshwar GH; Feng W; Reddy K; Plow EF; Byzova TV
Circ Res; 2007 Sep; 101(6):570-80. PubMed ID: 17641225
[TBL] [Abstract][Full Text] [Related]
18. Cryptotanshinone inhibits VEGF-induced angiogenesis by targeting the VEGFR2 signaling pathway.
Xu X; Wu L; Zhou X; Zhou N; Zhuang Q; Yang J; Dai J; Wang H; Chen S; Mao W
Microvasc Res; 2017 May; 111():25-31. PubMed ID: 28040437
[TBL] [Abstract][Full Text] [Related]
19. Integrin β3 crosstalk with VEGFR accommodating tyrosine phosphorylation as a regulatory switch.
West XZ; Meller N; Malinin NL; Deshmukh L; Meller J; Mahabeleshwar GH; Weber ME; Kerr BA; Vinogradova O; Byzova TV
PLoS One; 2012; 7(2):e31071. PubMed ID: 22363548
[TBL] [Abstract][Full Text] [Related]
20. Loss of osteoglycin promotes angiogenesis in limb ischaemia mouse models via modulation of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 signalling pathway.
Wu QH; Ma Y; Ruan CC; Yang Y; Liu XH; Ge Q; Kong LR; Zhang JW; Yan C; Gao PJ
Cardiovasc Res; 2017 Jan; 113(1):70-80. PubMed ID: 28069703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
